1. Isolation and characterization of rufoxin, a novel protein exhibiting neurotoxicity from venom of the psammophiine, Rhamphiophis oxyrhynchus (Rufous beaked snake).
- Author
-
Lumsden NG, Banerjee Y, Kini RM, Kuruppu S, and Hodgson WC
- Subjects
- Analysis of Variance, Animals, Chickens, Cholinesterase Inhibitors pharmacology, Chromatography, High Pressure Liquid methods, Colubridae, Dose-Response Relationship, Drug, In Vitro Techniques, Muscle Contraction drug effects, Neostigmine pharmacology, Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization methods, Time Factors, Neuromuscular Junction drug effects, Neurotoxins isolation & purification, Neurotoxins pharmacology, Snake Venoms chemistry
- Abstract
Colubrid snake venoms potentially represent a vast source of novel biological actives and structural motifs owing to their diverse phylogeny. The present study describes the identification of rufoxin, a neurotoxin from the venom of Rhamphiophis oxyrhynchus (Rufous beaked snake) which is a member of the African colubrid lineage, the psammophiines. Rufoxin (1 microM) displayed reversible post-synaptic neurotoxic activity as evidenced by significant inhibition of indirect twitches and responses to exogenous nicotinic agonists in the chick biventer cervicis nerve-muscle preparation. Rufoxin (0.1-1.0 microM) also caused a rightward parallel shift of cumulative concentration-response curves to carbachol (CCh; 0.6-80 microM) without a significant depression of the maximum response, suggestive of classical competitive antagonism at the skeletal muscle nicotinic receptor. Rufoxin lacks NH(2)-terminal sequence homology to previously identified snake venom toxins. This work indicates a wider distribution of neurotoxins across the advanced snake superfamily than previously described.
- Published
- 2007
- Full Text
- View/download PDF